Filing Details

Accession Number:
0001140361-18-032008
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-10 13:11:55
Reporting Period:
2018-07-06
Accepted Time:
2018-07-10 13:11:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447028 Arbutus Biopharma Corp ABUS Pharmaceutical Preparations (2834) 980597776
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635324 J. Michael Sofia C/O Arbutus Biopharma Corp.
Suite 100, 8900 Glenlyon Parkway
Burnaby A1 V5J 5J8
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2018-07-06 10,000 $8.45 1,523,403 No 4 S Direct
Common Shares Disposition 2018-07-09 10,000 $8.91 1,513,403 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 171,412 Indirect Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 22, 2014 (the "Trust")
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.50 to $9.35, inclusive. The reporting person undertakes to provide to Arbutus Biopharma Corp., any security holder of Arbutus Biopharma Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the rages set forth in this footnote.